Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
Scientific Reports|July 4, 2018
A selective high affinity MYC-binding compound inhibits MYC:MAX interaction and MYC-dependent tumor cell proliferationAlina Castell, Qinzi Yan, Karin Fawkner, et al.Redox Report : Communications in Free Radical Research|November 15, 2013
Mitochondrial targeting of α-tocopheryl succinate enhances its anti-mesothelioma efficacyJaromira Kovarova, Martina Bajzikova, Magdalena Vondrusova, et al.Apoptosis : an International Journal on Programmed Cell Death|January 10, 2013
Mitochondrial targeting overcomes ABCA1-dependent resistance of lung carcinoma to α-tocopheryl succinateLubomir Prochazka, Stepan Koudelka, Lan-Feng Dong, et al.Plos One|December 29, 2012
Alpha-tocopheryl succinate inhibits autophagic survival of prostate cancer cells induced by vitamin K3 and ascorbate to trigger cell deathMarco Tomasetti, Linda Nocchi, Jiri Neuzil, et al.Antioxidants & Redox Signaling|January 13, 2015
Mitochondrially targeted vitamin E succinate modulates expression of mitochondrial DNA transcripts and mitochondrial biogenesisJaroslav Truksa, Lan-Feng Dong, Jakub Rohlena, et al.Oncotarget|December 25, 2015
Interferon-γ-induced p27KIP1 binds to and targets MYC for proteasome-mediated degradationFuad Bahram, Per Hydbring, Susanna Tronnersjö, et al.Antioxidants & Redox Signaling|September 10, 2011
Mitochondrially targeted α-tocopheryl succinate is antiangiogenic: potential benefit against tumor angiogenesis but caution against wound healingJakub Rohlena, Lan-Feng Dong, Katarina Kluckova, et al.Antioxidants & Redox Signaling|January 22, 2014
MicroRNA-126 suppresses mesothelioma malignancy by targeting IRS1 and interfering with the mitochondrial functionMarco Tomasetti, Linda Nocchi, Sara Staffolani, et al.Oncotarget|April 28, 2016
MicroRNA-126 induces autophagy by altering cell metabolism in malignant mesotheliomaMarco Tomasetti, Federica Monaco, Nicola Manzella, et al.Plos One|May 18, 2016
Correction: Characterisation of Mesothelioma-Initiating Cells and Their Susceptibility to Anti-Cancer AgentsElham Alizadeh Pasdar, Michael Smits, Michael Stapelberg, et al.Pageof 3